CASP1 and non-small cell lung carcinoma: Wang et al. discovered that SNHG5 was downregulated in NSCLC tissues, and high SNHG5 expression may enhance the sensitivity of A549 cells to gefitinib by interacting with the miR377/CASP1 axis [63].